Literature DB >> 22970032

Relationship between XRCC1 and XPD polymorphisms and the risk of the development of hepatocellular carcinoma: A case-control study.

Tao Yuan1, Shaoli Deng, Hongming Liu, Menggang Liu, Ping Chen.   

Abstract

Hepatocellular carcinoma (HCC) is a serious public health issue, the incidence of which is considered to be closely related to tobacco smoking, alcohol consumption, hepatitis B virus (HBV) infection and family history. The DNA repair system is an important protective mechanism against the development of malignant cells induced by internal and external environmental factors. The aim of this study was to investigate the association of polymorphisms of XRCC1-194, XRCC1-280 and XPD-312 DNA repair genes and the risk of development of HCC in Han Chinese patients. A case-control design was used including 252 HCC inpatients and 250 healthy controls recruited and matched by age, gender, tobacco smoking, alcohol consumption, HBV infection and family history. XPD Asp312Asn, XRCC1 Arg194Trp and XRCC1 Arg280His genes were examined using a sequencing assay method. Distributions of the genotype frequency and odds ratio (OR) between the two groups were analyzed. The results demonstrated that there was no significant difference in the frequencies of XPD Asp312Asn, XRCC1 Arg194Trp and XRCC1 Arg280His in the HCC cases and the control group. In the stratified analysis of different allele genotypes, the frequency of the XRCC1-194 site genotype was not significantly different between the case and control group. The presence of the XRCC1 280His genotype was associated with a significantly increased risk of HCC under conditions of HBV infection and family history [OR (95% CI): 1.68 (1.08-2.60), 4.20 (1.34-13.20), respectively]. Similarly, the XPD 312Asn significantly increased the risk of HCC under conditions of alcohol consumption, tobacco smoking, HBV infection and family history [OR (95% CI): 1.67 (1.10-2.60), 1.87 (1.18-2.96), 1.96 (1.24-3.10), 3.40 (1.32-8.76), respectively]. In conclusion, tobacco smoking and alcohol consumption are high risk factors of HCC for the XPD 312Asn genotype; HBV infection and family history increase the risk of HCC for the genotypes XRCC1 280His and XPD 312Asn.

Entities:  

Year:  2012        PMID: 22970032      PMCID: PMC3439166          DOI: 10.3892/etm.2012.581

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  24 in total

1.  XRCC1 polymorphisms: effects on aflatoxin B1-DNA adducts and glycophorin A variant frequency.

Authors:  R M Lunn; R G Langlois; L L Hsieh; C L Thompson; D A Bell
Journal:  Cancer Res       Date:  1999-06-01       Impact factor: 12.701

Review 2.  Quality control by DNA repair.

Authors:  T Lindahl; R D Wood
Journal:  Science       Date:  1999-12-03       Impact factor: 47.728

3.  Genetic polymorphisms of XRCC1 and risk of gastric cancer.

Authors:  Seong-Gene Lee; Byungsik Kim; Jaewon Choi; Changhoon Kim; Inchul Lee; Kyuyoung Song
Journal:  Cancer Lett       Date:  2002-12-10       Impact factor: 8.679

4.  The polymorphisms of GSTM1, GSTT1, HYL1*2, and XRCC1, and aflatoxin B1-related hepatocellular carcinoma in Guangxi population, China.

Authors:  Xi Dai Long; Yun Ma; Yi Ping Wei; Zhou Lin Deng
Journal:  Hepatol Res       Date:  2006-08-01       Impact factor: 4.288

Review 5.  Polymorphism in the DNA repair enzyme XRCC1: utility of current database and implications for human health risk assessment.

Authors:  Gary Ginsberg; Kenneth Angle; Kathryn Guyton; Babasaheb Sonawane
Journal:  Mutat Res       Date:  2011-02-23       Impact factor: 2.433

6.  ERCC1, XPD and RAI mRNA levels in lymphocytes are not associated with lung cancer risk in a prospective study of Danes.

Authors:  Ulla Vogel; Bjørn A Nexø; Anne Tjønneland; Håkan Wallin; Ole Hertel; Ole Raaschou-Nielsen
Journal:  Mutat Res       Date:  2005-07-28       Impact factor: 2.433

7.  Reduced expression levels of nucleotide excision repair genes in lung cancer: a case-control analysis.

Authors:  L Cheng; M R Spitz; W K Hong; Q Wei
Journal:  Carcinogenesis       Date:  2000-08       Impact factor: 4.944

Review 8.  HMGNs, DNA repair and cancer.

Authors:  Gabi Gerlitz
Journal:  Biochim Biophys Acta       Date:  2009-12-08

9.  CYP enzyme polymorphisms and susceptibility to HCV-related chronic liver disease and liver cancer.

Authors:  Laura Silvestri; Laura Sonzogni; Annalisa De Silvestri; Chiara Gritti; Luciana Foti; Claudio Zavaglia; Michela Leveri; Agostino Cividini; Mario U Mondelli; Emilio Civardi; Enrico M Silini
Journal:  Int J Cancer       Date:  2003-04-10       Impact factor: 7.396

10.  XPD codon 312 and 751 polymorphisms, and AFB1 exposure, and hepatocellular carcinoma risk.

Authors:  Xi Dai Long; Yun Ma; Yun Feng Zhou; Jin Guang Yao; Fu Zhi Ban; Yong Zhi Huang; Bing Cheng Huang
Journal:  BMC Cancer       Date:  2009-11-17       Impact factor: 4.430

View more
  8 in total

1.  A meta-analysis of xeroderma pigmentosum gene D Ls751Gln polymorphism and susceptibility to hepatocellular carcinoma.

Authors:  Yu Wang; Yingren Zhao; Aiyun Zhang; Juan Ma; Zhenzhen Wang; Xu Zhang
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

2.  Polymorphisms of excision repair gene XPD Lys751Gln and hOGG1 Ser326Cys might not be associated with hepatocellular carcinoma risk: a meta-analysis.

Authors:  Ri-Chu Zhang; Si-Hua Mou
Journal:  Tumour Biol       Date:  2012-12-28

3.  XPD Functions as a Tumor Suppressor and Dysregulates Autophagy in Cultured HepG2 Cells.

Authors:  Jian-Feng Zheng; Lin-Lin Li; Juan Lu; Kun Yan; Wu-Hua Guo; Ji-Xiang Zhang
Journal:  Med Sci Monit       Date:  2015-05-29

Review 4.  Association between XPD Lys751Gln and Asp312Asn polymorphisms and hepatocellular carcinoma risk: a systematic review and meta-analysis.

Authors:  Qiliu Peng; Shan Li; Xianjun Lao; Zhiping Chen; Ruolin Li; Xue Qin
Journal:  Medicine (Baltimore)       Date:  2014-12       Impact factor: 1.889

5.  The association of six non-synonymous variants in three DNA repair genes with hepatocellular carcinoma risk: a meta-analysis.

Authors:  Yan-Hui Shi; Bin Wang; Bai-Ping Xu; Dan-Na Jiang; Dong-Mei Zhao; Man-Ru Ji; Li Zhou; Xue Li; Chang-Zhu Lu
Journal:  J Cell Mol Med       Date:  2016-06-16       Impact factor: 5.310

6.  Associations between three XRCC1 polymorphisms and hepatocellular carcinoma risk: A meta-analysis of case-control studies.

Authors:  Yao Xiong; Qian Zhang; Jiaxiang Ye; Shan Pan; Lianying Ge
Journal:  PLoS One       Date:  2018-11-08       Impact factor: 3.240

7.  XPD suppresses cell proliferation and migration via miR-29a-3p-Mdm2/PDGF-B axis in HCC.

Authors:  Zhihua Xiao; Yijun Wang; Hao Ding
Journal:  Cell Biosci       Date:  2019-01-05       Impact factor: 7.133

8.  DNA repair gene XRCC1 Arg194Trp polymorphism and susceptibility to hepatocellular carcinoma: A meta-analysis.

Authors:  Wenyan Li; Feng Yang; Yongxian Gui; Junjie Bian
Journal:  Oncol Lett       Date:  2014-07-15       Impact factor: 2.967

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.